# TYBLUME
> **NDA209405** · New Drug Application · Sponsor: EXELTIS USA INC · Approved 2020-03-30
## Drug
- **FDA Application Number:** NDA209405
- **Application type:** New Drug Application
- **Brand name:** TYBLUME
- **Generic name:** LEVONORGESTREL AND ETHINYL ESTRADIOL
- **Active ingredients:** ETHINYL ESTRADIOL; LEVONORGESTREL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EXELTIS USA INC
- **Manufacturer:** Exeltis USA, Inc.
- **First approval:** 2020-03-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209405)
---
*MORVS · CC0 1.0*